Distribution of Macrolide Resistant Mycoplasma genitalium in Urogenital Tract Specimens From Women Enrolled in a US Clinical Study Cohort
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciac602 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Damon Getman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Hologic, Inc, San Diego, California, USA. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Mycoplasma Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hologic, Inc.
Abstract (Originalsprache)
Background
This study evaluated the distribution of macrolide-resistant Mycoplasma genitalium in multiple urogenital specimens collected from women enrolled in a prospective multicenter US clinical study.
Methods
Four female urogenital specimens (vaginal swab, urine, endocervical swab, ectocervical brush/spatula) collected from each subject were tested using a transcription-mediated amplification (TMA) assay for M. genitalium. TMA-positive specimens were evaluated by reverse transcription–polymerase chain reaction and bidirectional Sanger sequencing of M. genitalium 23S rRNA to identify the presence of macrolide-resistance–mediating mutations (MRMs) at base positions 2058/2059.
Results
Of 140 women with ≥1 TMA-positive specimens, 128 (91.4%) yielded M. genitalium 23S rRNA sequence. MRMs were found in 52% of vaginal specimens, 46.3% of urine specimens, 37.8% of endocervical specimens, and 46% of ectocervical specimens. There were 44 unique specimen type/sequence phenotype combinations of M. genitalium infection. Most (81; 63.3%) women had single specimen-sequence phenotype (macrolide-susceptible, MRM, or both) infections, while 24 (18.8%) women had multiple specimen-sequence phenotype concordant infections, and 23 (17.9%) women had multiple specimen-sequence phenotype discordant infections. The sensitivity for any single specimen type to detect overall urogenital tract macrolide-resistant M. genitalium infection status was 96.3% for vaginal swab samples, 82.6% for urine samples, 70.8% for endocervical swab samples, and 82.1% for ectocervical brush/spatula liquid Pap samples.
Conclusions
The distribution of M. genitalium infections in female urogenital tract specimens is highly complex, with multiple phenotypic combinations of the organism infecting a significant proportion of women at different anatomic specimen collection sites. Vaginal swab sampling yielded the highest sensitivity for identifying women with macrolide-resistant M. genitalium urogenital tract infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development, Hologic, Inc, San Diego, California, USA.
- Department of Emergency Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
ORCID-Profile: Damon Getman
Förderung
- Hologic, Inc
Zitieren
APA
Getman, D., Cohen, S., & Jiang, A. (2023). Distribution of Macrolide Resistant Mycoplasma genitalium in Urogenital Tract Specimens From Women Enrolled in a US Clinical Study Cohort. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac602
Vancouver
Getman D, Cohen S, Jiang A. Distribution of Macrolide Resistant Mycoplasma genitalium in Urogenital Tract Specimens From Women Enrolled in a US Clinical Study Cohort. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac602
BibTeX
@article{Getman2023,
author = {Getman, Damon and Cohen, Seth and Jiang, Alice},
title = {Distribution of Macrolide Resistant Mycoplasma genitalium in Urogenital Tract Specimens From Women Enrolled in a US Clinical Study Cohort},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciac602}
}
EUVIMED